Zentalis Pharmaceuticals Inc at TD Cowen Oncology Innovation Summit (Virtual) Transcript
Everyone had a great long weekend. Tyler Van Buren here, Senior Biotech Analyst at TD Cowen. Thank you very much for joining TD Cowen's Seventh Oncology Summit.
For our next session, we have a Q&A with Zentalis, and it's my pleasure to introduce Julie Eastland, the CEO and President of Zentalis, and Ingmar Bruns, the Chief Medical Officer. Julie and Ingmar, it's a privilege to have you both here. Thank you for joining me.
Thanks, Tyler, we always appreciate it.
Of course. So before we get started with the discussion, for those of you in the audience, feel free to email me questions at [email protected]. You can also use cowen.com, but again, that's first.last, and we'll do our best to get them asked before the end of the discussion.
Also, as you all may know, our favorite season, which is Extel voting season, kicks
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
